Christina Sylvest

First Clinical Study with AP30663 ‐ a KCa2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation

U. Sørensen, J. Burggraaf, M. Grunnet, 2020, Clinical and translational science.